Rheumatoid arthritis in a mouse?
作者信息
Firestein Gary S
出版信息
Nat Clin Pract Rheumatol. 2009 Jan;5(1):1. doi: 10.1038/ncprheum0973.
Abstract
摘要
相似文献
1
Rheumatoid arthritis in a mouse?
Nat Clin Pract Rheumatol. 2009 Jan;5(1):1. doi: 10.1038/ncprheum0973.
2
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.
Ann Rheum Dis. 2008 Nov;67(11):1505-15. doi: 10.1136/ard.2007.076430. Epub 2007 Nov 29.
3
[SCID-HuRAg mouse].
Nihon Rinsho. 2005 Jan;63 Suppl 1:59-67.
4
[The relevance of animal experiments to human arthritis and the effect of drug therapy on experimentally induced arthritis in animals].
Z Rheumatol. 1983 Jul-Aug;42(4):159-70.
5
Animal models of rheumatoid arthritis.
Eur J Immunol. 2009 Aug;39(8):2040-4. doi: 10.1002/eji.200939578.
6
Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis.
J Mol Med (Berl). 2020 Apr;98(4):585-593. doi: 10.1007/s00109-020-01889-9. Epub 2020 Feb 27.
7
In Vivo Models of Rheumatoid Arthritis.
Methods Mol Biol. 2019;1914:269-280. doi: 10.1007/978-1-4939-8997-3_14.
8
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis.
Ann Rheum Dis. 2010 May;69(5):898-902. doi: 10.1136/ard.2008.106021. Epub 2009 Jun 3.
9
Adjuvant arthritis.
Arzneimittelforschung. 1976;26(10):1860-6.
10
[Evaluation of immunomodulators in animal experimental models of rheumatoid arthritis].
Ryumachi. 1988 Dec;28(6):450-2.
引用本文的文献
1
Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis.
Adv Sci (Weinh). 2023 Apr;10(11):e2202720. doi: 10.1002/advs.202202720. Epub 2023 Mar 8.
2
Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis.
Front Endocrinol (Lausanne). 2022 Jun 2;13:905756. doi: 10.3389/fendo.2022.905756. eCollection 2022.
3
Therapeutic Effects of Hypoxic and Pro-Inflammatory Priming of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Inflammatory Arthritis.
Int J Mol Sci. 2021 Dec 23;23(1):126. doi: 10.3390/ijms23010126.
4
Modeling Rheumatoid Arthritis In Vitro: From Experimental Feasibility to Physiological Proximity.
Int J Mol Sci. 2020 Oct 25;21(21):7916. doi: 10.3390/ijms21217916.
5
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis.
JCI Insight. 2020 Oct 15;5(20):141868. doi: 10.1172/jci.insight.141868.
6
Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal.
Sci Adv. 2020 Jun 26;6(26):eaba4353. doi: 10.1126/sciadv.aba4353. eCollection 2020 Jun.
7
Development of macromolecular prodrug for rheumatoid arthritis.
Adv Drug Deliv Rev. 2012 Sep;64(12):1205-19. doi: 10.1016/j.addr.2012.03.006. Epub 2012 Mar 10.
8
c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Arthritis Res Ther. 2010;12(1):R32. doi: 10.1186/ar2940. Epub 2010 Feb 24.
9
"Go upstream, young man": lessons learned from the p38 saga.
Ann Rheum Dis. 2010 Jan;69 Suppl 1(Suppl 1):i77-82. doi: 10.1136/ard.2009.119479.
10
The as-yet unfulfilled promise of p38 MAPK inhibitors.
Nat Rev Rheumatol. 2009 Sep;5(9):475-7. doi: 10.1038/nrrheum.2009.171.
Zotero 插件